US equities
|
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMZN
$251.40
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
SNDK
$1,704.16
▲+0.00%
TSLA
$378.73
▲+0.00%
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMZN
$251.40
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
SNDK
$1,704.16
▲+0.00%
TSLA
$378.73
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Predictive Oncology Inc. - Common Stock
(NQ:
POAI
)
5.950
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Predictive Oncology Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
July 26, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
↗
July 25, 2024
Predictive Oncology’s AI-driven platform demonstrated predictive utility in oncology, thereby providing credibility to POAI stock.
Via
InvestorPlace
Why Predicitive Oncology Stock Is Soaring
↗
July 25, 2024
Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers....
Via
Benzinga
Topics
Artificial Intelligence
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
↗
July 25, 2024
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 25, 2024
Via
Benzinga
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
↗
July 25, 2024
Via
Benzinga
Topics
Stocks
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
July 25, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
July 25, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
↗
June 28, 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Via
InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
June 11, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
June 11, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
June 04, 2024
Via
Investor Brand Network
Topics
Animal Testing
Artificial Intelligence
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
May 29, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 29, 2024
Via
Benzinga
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
May 29, 2024
Via
Benzinga
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners...
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 28, 2024
Via
Benzinga
Why Predictive Oncology (POAI) Stock Is Skyrocketing
↗
May 28, 2024
Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.
Via
Benzinga
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
May 28, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 28, 2024
Via
Benzinga
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Q1 2024 Financial Results, Provides Business Update
May 15, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
POAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024
↗
May 15, 2024
Predictive Oncology just reported results for the first quarter of 2024.
Via
InvestorPlace
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
Company to host investor call and webcast today, May 15th, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q1 2024 Financial Results, Conference Call
May 10, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024
Management to host conference call and webcast at 8:30am ET
From
Predictive Oncology Inc.
Via
GlobeNewswire
The 3 Most Undervalued AI Penny Stocks to Buy in May 2024
↗
May 08, 2024
As the economy steadies, undervalued AI penny stocks represent a speculative yet promising frontier for risk-taking investors.
Via
InvestorPlace
Topics
Artificial Intelligence
Economy
AI-Fueled Penny Stocks: 3 High-Risk, High-Reward Opportunities
↗
May 08, 2024
AI penny stocks require an appetite for risk that offers the chance at outsized returns that are difficult to find elsewhere.
Via
InvestorPlace
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
